Enhanced medical treatment in diabetic cardiomyopathy
US2007264246A1
ENHANCED MEDICAL TREATMENTS RESULTING FROM CHEMICAL IDENTIFICATION OF CALCIUM INFLUX FACTOR, IDENTITY WITH THE FACTOR ACTIVATING PHOSPHOLIPOLYSIS AND PRECIPITATING SUDDEN DEATH DURING MYOCARDIAL INFARCTION, AND DETERMINATION OF SIMILAR ACTIVATING MECHANISMS IN MULTIPLE CELL TYPES THROUGH DISINHIBITION OF CALCIUM-INDEPENDENT PHOSPHOLIPASE A2beta
US2006051841A1
Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities
US2005208031A1
Inhibition of calcium-independent phospholipases A2beta or A2gamma inhibit hormone-induced differentiation of 3T3-L1 preadipocytes
US7510880B2
Multidimensional mass spectrometry of serum and cellular lipids directly from biologic extracts